Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer therapy

Immunotherapy at all stages of hepatocellular carcinoma

Nature Medicine volume 30, pages 640–641 (2024)Cite this article

Subjects

A flurry of emerging treatment options is transforming the therapeutic landscape of hepatocellular carcinoma; two new studies highlight the complexities and gaps in knowledge, but also hint at a greater understanding of how to apply immunotherapy in early and advanced disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wang, K. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02786-7 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kim, H.-D. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02824-y (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Qin, S. et al. Lancet 402, 1835–1847 (2023).

    Article  CAS  PubMed  Google Scholar 

  4. de Gramont, A. et al. Lancet Oncol. 13, 1225–1233 (2012).

    Article  PubMed  Google Scholar 

  5. Wakelee, H. A. et al. Lancet Oncol. 18, 1610–1623 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang, A. C. et al. Nature 545, 60–65 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhu, A. X. et al. Nat. Med. 28, 1599–1611 (2022).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK

    David J. Pinato, Claudia A. M. Fulgenzi & Antonio D’Alessio

  2. Department of Translational Medicine, Università Del Piemonte Orientale “A. Avogadro”, Novara, Italy

    David J. Pinato & Antonio D’Alessio

Authors
  1. David J. Pinato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia A. M. Fulgenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio D’Alessio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Pinato.

Ethics declarations

Competing interests

D.J.P. received lecture fees from ViiV Healthcare, Bayer Healthcare, BMS, Roche, Eisai and Falk Foundation; travel expenses from BMS and Bayer Healthcare; consulting fees for Mina Therapeutics, EISAI, Roche, DaVolterra, Mursla, Exact Sciences and Astra Zeneca; and research funding (to their institution) from MSD and BMS. A.D. received educational support for congress attendance from Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinato, D.J., Fulgenzi, C.A.M. & D’Alessio, A. Immunotherapy at all stages of hepatocellular carcinoma. Nat Med 30, 640–641 (2024). https://doi.org/10.1038/s41591-024-02828-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02828-8

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing